These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28638446)

  • 1. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
    J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
    Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ
    Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH
    Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
    J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.
    Lin CY; Sheu MJ; Li CF; Lee SW; Lin LC; Wang YF; Chen SH
    Tumour Biol; 2014 Jul; 35(7):6823-30. PubMed ID: 24729124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
    Chen TJ; He HL; Shiue YL; Yang CC; Lin LC; Tian YF; Chen SH
    Int J Med Sci; 2018; 15(11):1171-1178. PubMed ID: 30123054
    [No Abstract]   [Full Text] [Related]  

  • 8. CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT.
    Chou CL; Chen TJ; Tian YF; Chan TC; Yeh CF; Li WS; Tsai HH; Li CF; Lai HY
    Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
    Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.
    Lin SC; Chang IW; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Tian YF
    J Cancer; 2017; 8(14):2756-2764. PubMed ID: 28928864
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
    J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Tian YF; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Solórzano J; Li CF; Chang IW
    J Cancer; 2017; 8(7):1197-1204. PubMed ID: 28607594
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF
    Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT.
    Li WS; Chen TJ; Lee SW; Yang CC; Tian YF; Kuo YH; Tsai HH; Wu LC; Yeh CF; Shiue YL; Chou CL; Lai HY
    Histol Histopathol; 2024 Jan; 39(1):91-104. PubMed ID: 37042618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VNN1 overexpression is associated with poor response to preoperative chemoradiotherapy and adverse prognosis in patients with rectal cancers.
    Chai CY; Zhang Y; Song J; Lin SC; Sun S; Chang IW
    Am J Transl Res; 2016; 8(10):4455-4463. PubMed ID: 27830030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.
    Chen TJ; Chou CL; Tian YF; Yeh CF; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Int J Clin Oncol; 2021 Sep; 26(9):1689-1697. PubMed ID: 34043102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
    Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT.
    Chen HP; Chen CI; Liu KW; Chen TJ; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Li CF; Chou CL; Lai HY
    Pathol Res Pract; 2022 Nov; 239():154158. PubMed ID: 36244249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
    Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
    Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.
    Chou CL; Chen TJ; Lin CY; Lee SW; Wang SC; Chu SS; Yang CC
    Onco Targets Ther; 2020; 13():3141-3150. PubMed ID: 32346297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.